Florian Muller

11PUBLICATIONS
52CO-AUTHORS
Medical infection agents (incl. prions)Proteomics and intermolecular interactions (excl. medical proteomics)PharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 31, 2024
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection.

Jillian E Milanes, Victoria C Yan, Cong-Dat Pham

|Mar 09, 2023
Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenase.

Kevin G Hicks, Ahmad A Cluntun, Heidi L Schubert

|Feb 17, 2023
Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration.

Victoria C Yan, Yasaman Barekatain, Yu-Hsi Lin

|Oct 17, 2022
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers.

Victoria C Yan, Cong-Dat Pham, Elliot S Ballato

|Jul 06, 2022
Quantification of Phosphonate Drugs by 1H-31P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than Mice.

Yasaman Barekatain, Sunada Khadka, Kristen Harris

|Jul 10, 2021
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine.

Yasaman Barekatain, Jeffrey J Ackroyd, Victoria C Yan

Pageof 2